AnaptysBio Inc (ANAB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO, CA 92121

AnaptysBio, Inc. operates as a clinical stage biotechnology company. The Company manufactures and markets antibodies for cancer immunotherapy and inflammation. AnaptysBio has primary operations in the United States.

Data as of 2020-05-30
Market Cap520.447 Million Shares Outstanding27.277 Million Avg 30-day Volume374.744 Thousand
P/E Ratio Dividend Yield EPS-3.09
Price/Sales22.628 Price cash flow ratio Price free cash flow ratio-7.6
Book Value14.69 Price to Tangible Book1.31 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low77.285 / 10.0 Stddev
View SEC Filings from ANAB instead.

View recent insider trading info

Funds Holding ANAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANAB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-05-21 1

LYDON NICHOLAS

  • Director
87,727 2020-05-15 0

RENTON HOLLINGS

  • Director
0 2020-05-08 1

NOVO HOLDINGS A/S

  • 10% Owner
2,927,560 2020-04-30 0

PISCITELLI DOMINIC CHIEF FINANCIAL OFFICER

  • Officer
0 2020-04-23 0

SURIA HAMZA PRESIDENT, CEO

  • Officer
  • Director
47,636 2020-03-10 5

SCHMID JOHN P.

  • Director
0 2020-02-12 1

WARE J. ANTHONY

  • Director
0 2020-02-12 2

FENTON DENNIS M

  • Director
0 2020-02-12 1

HAMILL LAURA

  • Director
0 2020-02-12 3

SCHOENECK JAMES A INTERIM PRESIDENT

  • Officer
  • Director
22,422 2020-01-06 0

LONDEI MARCO CHIEF MEDICAL OFFICER

  • Officer
0 2019-12-06 3

LOUMEAU ERIC J GENERAL COUNSEL & INTERIM CFO

  • Officer
0 2019-12-06 2

GALLAGHER CAROL GILTNER

  • Director
0 2019-07-24 0

FRAZIER HEALTHCARE VII, L.P.

FRAZIER HEALTHCARE VII-A, L.P.

FHM VII, L.P.

FHM VII, L.L.C.

FRAZIER ALAN D

NAINI NADER J

EVERY NATHAN R

HERON PATRICK J

  • 10% Owner
No longer subject to file 2018-05-11 0

FRAZIER HEALTHCARE V, LP

FHM V, LP

FHM V, LLC

FRAZIER ALAN D

NAINI NADER J

EVERY NATHAN R

HERON PATRICK J

  • 10% Owner
No longer subject to file 2018-05-11 0

AVALON VENTURES VII L P

AVALON VENTURES VII GP, LLC

KINSELLA KEVIN J

TOMLIN STEPHEN LAWRENCE

  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2017-07-26 0

MOYLE MATTHEW CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-02-24 0

AVALON VENTURES VII L P

KINSELLA KEVIN J

TOMLIN STEPHEN LAWRENCE

  • 10% Owner
2,036,932 2017-01-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
PDT Partners, LLC AnaptysBio, Inc. 0.59% 2018-02-07 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
PDT Partners, LLC AnaptysBio, Inc. 0.68% 2018-01-25 GERMANY
PDT Partners, LLC AnaptysBio, Inc. 0.7% 2018-01-24 GERMANY

Elevate your investments